Skip to content
Thomson Reuters
Corporate Governance

Chemed to pay $75 million over false claims lawsuit: Justice Dept

Reuters Staff

30 Oct 2017

WASHINGTON (Reuters) – Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

The allegations relate to billing for ineligible patients and inflated levels of care, the department said in a statement. Vitas Hospice Services is the largest U.S. for-profit hospice chain, it said.

Reporting by Eric Walsh; Editing by Mohammad Zargham
Our Standards:The Thomson Reuters Trust Principles.
H&M, C&A, 3M investigate China prison labor report Facebook plans to use U.S. mail to verify IDs of election ad buyers Unilever lays bare palm oil supply chain in rare industry move Release: Largest office building ever to receive ENERGY STAR certification Unilever threatens online ad cuts to clean up internet British banks Lloyds and RBS set ethnic targets for top roles India’s antitrust watchdog fines Google for abusing dominant position Britain’s Tesco faces record $5.6 billion equal pay claim World Bank launches $1.4 billion catastrophe bond for Latam earthquakes: Aon Lawmakers, advocates urge Trump administration to resume Equifax probe